TaiMed Biologics Free Cash Flow Generation Index

Latest as of June 2026: 0.55x

TaiMed Biologics free cash flow generation index. TaiMed Biologics (4147) has a Free Cash Flow Generation Index of 0.55x as of June 2026. Free cash flow of NT$32.53 Million represents 1% of operating cash flow (NT$58.88 Million). Check how resilient are TaiMed Biologics's assets to evaluate the company's liquid asset resilience ratio.

FCF Generation Index

0.55x

Free Cash Flow / Operating CF

Free Cash Flow

NT$32.53 Million

TWD

Operating Cash Flow

NT$58.88 Million

TWD

Capital Expenditures

NT$26.35 Million

TWD

Free Cash Flow Generation Index of TaiMed Biologics (2025–2025)

Free cash flow generation index of TaiMed Biologics from 2025 to 2025. Historical FCF Generation Index trend for TaiMed Biologics across 1 annual periods. Explore TaiMed Biologics (4147) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

TaiMed Biologics Free Cash Flow Generation Index by Year (2025–2025)

TaiMed Biologics free cash flow generation index by year from 2025 to 2025. Year-by-year Free Cash Flow Generation Index for TaiMed Biologics. For the full cash flow conversion analysis, see 4147 cash flow conversion.

Year	FCG Index	Free Cash Flow (TWD)	Operating CF	Capital Expenditures	YoY Change
2025	0.88x	NT$168.38 Million	NT$191.14 Million	NT$22.77 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).